Clinical Practice Guidelines: Still Conflicted After All These Years

Clinical Practice Guidelines: Still Conflicted After All These Years

By Unknown at 9:53 AM

Background: Untrustworthy Clinical Practice Guidelines Since the 1990s, clinicians have been exhorted to follow clinical practice guidelines...

Academic Medical Leaders as Directors of For-Profit Health Care Corporations: the Prevalence of This "New Species" of Conflict of Interest Documented in the BMJ

Academic Medical Leaders as Directors of For-Profit Health Care Corporations: the Prevalence of This "New Species" of Conflict of Interest Documented in the BMJ

By Unknown at 12:39 PM

The important conflicts of interest generated when academic health care leaders also serve on the boards of directors of for-profit health ...

How Institutional Conflicts of Interest Exacerbate the Anechoic Effect - the Example of ASCO Fearing "Biting the Hand that Feeds You"

How Institutional Conflicts of Interest Exacerbate the Anechoic Effect - the Example of ASCO Fearing "Biting the Hand that Feeds You"

By Unknown at 12:42 PM

As we recently discussed ( here , here , here and here ), in May, 2015, the New England Journal of Medicine, arguably the world's forem...

By Unknown at 1:59 PM

Why is the New England Journal of Medicine Scolding "Pharmascolds"? I, a normally quiet blogger on this site, was disquieted by wh...

Oh, the Prices we Pay ... for Questionable Drug Marketing to Enrich Corporate Insiders - the Case of Questcor's H P Acthar Revisited

Oh, the Prices we Pay ... for Questionable Drug Marketing to Enrich Corporate Insiders - the Case of Questcor's H P Acthar Revisited

By Unknown at 7:57 AM

In 2007, we first discussed the case of the amazing pricing of H P Acthar, a very old drug of questionable usefulness, as an example of the...